Brookdale Senior Living Inc. (BKD)

NYSE: BKD · USD

$9.97

+0.44 (+4.6%)· Recorded snapshot

Market cap	2.4B
Revenue (ttm)	2.9B
Net income (ttm)	-138.3M
EPS (ttm)	-$0.58
Shares out	238.8M
P/E (forward)	411.3x
Volume	4,785,111
Beta	0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.9B
Net income (ttm): -138.3M
EPS (ttm): -$0.58
P/E (forward): 411.3x
Market cap: 2.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E411.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-349.6

P25 n/aP50 n/aP75 n/a

ROIC2.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BKD indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001332349
Company name	Brookdale Senior Living Inc.
Country	United States
Country code	US
CUSIP number	112463104
Earnings date	2026-11-06
Earnings time	bmo
Employees	33,000
Employees change	-3,000
Employees growth	-8.33%
Enterprise value	$7.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2005-11-22
Is primary listing	Yes
Is SPAC	No
ISIN number	US1124631045
Last 10-K release date	2026-02-19
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-06
Options	Yes
Price	$9.97
Price currency	USD
Sector	Healthcare
SIC code	8050
Stock price date	2026-10-28
Symbol	BKD
U.S. state	Tennessee
Website	https://www.brookdale.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-5.84%
EV/EBIT	50.18x
EV/EBITDA	16.04x
EV/FCF	30,815.84x
EV/Sales	2.54x
FCF / EV yield	0%
FCF yield	0.01%
Forward EV/Sales	2.54x
Forward P/E	411.25x
Forward P/S	0.8x
Industry forward P/E	14.81x
Industry P/E	18.21x
P/(OCF - SBC) ratio	11.14x
P/FCF ratio	9,739.01x
P/OCF ratio	10.53x
P/S ratio	0.8x
Price/EBITDA ratio	5.07x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.07%
EBITDA margin	15.85%
FCF margin	0.01%
Gross margin	28.26%
Operating margin	5.07%
Pretax margin	-4.58%
Profit margin	-4.72%
Profit per employee	$-4,191
Profitable quarters	1
Revenue per employee	$88,858
ROA	1.54%
ROA (5Y)	-0.31%
ROCE	2.76%
ROE	-349.58%
ROE (5Y)	-92.4%
ROIC	2.77%
ROIC (5Y)	-0.63%
SBC / revenue	0.42%
Tax / revenue	0.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
FCF growth (Q)	-31.24%
Gross profit growth	-0.55%
Gross profit growth (Q)	-4.7%
Gross profit growth 3Y	9.59%
Gross profit growth 5Y	6.59%
Net income growth quarters	3
Net income growth years	0
OCF growth	2.4%
OCF growth (Q)	9.99%
OCF growth (QoQ)	340.06%
OCF growth 10Y	-4.62%
OCF growth 3Y	29.61%
Operating income growth	82.56%
Operating income growth (Q)	85.99%
Revenue growth	-3.91%
Revenue growth (Q)	-8.87%
Revenue growth (QoQ)	-2.56%
Revenue growth 10Y	-3.67%
Revenue growth 3Y	2.26%
Revenue growth 5Y	1.32%
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-223.6M
Depreciation and amortization	$316.3M
EBIT	$148.6M
EBITDA	$464.9M
EPS	$-0.58
FCF per share	$0.00
Financing cash flow	$-35M
Free cash flow	$242,000
Free cash flow minus SBC	$-12M
Gross profit	$828.6M
Income taxes	$4.1M
Investing cash flow	$-70.9M
Net borrowing	$2.3M
Net cash flow	$118M
Net income	$-138.3M
Operating cash flow minus SBC	$211.6M
Operating income	$148.6M
Revenue	$2.9B
Stock-based compensation	$12.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.15
Book value per share	$-0.12
Debt / EBITDA	8.38
Debt / FCF	22,689.61
Goodwill	$27.3M
Interest coverage	0.6
Long-term assets	$5.3B
Long-term liabilities	$5.4B
Net cash (debt)	$-5.1B
Net cash / market cap	-216.42%
Net debt / EBITDA	10.97
Net debt / FCF	21,076.83
Piotroski F-Score	6
Property, plant and equipment	$5.2B
Shareholders' equity	$-27.6M
Tangible book value	$-56.3M
Tangible book value per share	$-0.24
Total assets	$5.9B
Total cash	$390.3M
Total debt	$5.5B
Total liabilities	$5.9B
WACC	4.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	$597.1M
Current liabilities	$522.5M
Current ratio	1.14
Net working capital	$-163.9M
Quick ratio	0.85
Working capital	$74.6M
Working capital turnover	-248.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.21%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.25
Shareholder yield	-3.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-33.65%
10Y return CAGR	-4.02%
10Y total return	-33.65%
150-day SMA	$12.96
15Y price change	-40.39%
15Y return CAGR	-3.39%
15Y total return	-40.39%
1D price change	4.62%
1M price change	-11.25%
1M total return	-11.25%
1W price change	-2.09%
1W total return	-2.09%
1Y price change	12.69%
1Y return CAGR	12.7%
1Y total return	12.69%
20-day SMA	$10.25
200-day SMA	$13.34
20Y price change	-79.48%
20Y return CAGR	-7.17%
20Y total return	-77.41%
3M price change	-36.26%
3M total return	-36.26%
3Y price change	150.89%
3Y return CAGR	35.87%
3Y total return	150.89%
50-day SMA	$11.13
50-day SMA vs 200-day SMA	50under200
52-week high	$17.09
52-week high date	2026-02-17
52-week low	$8.02
52-week low date	2025-11-07
5Y price change	51%
5Y return CAGR	8.59%
5Y total return	51%
6M price change	-29.32%
6M total return	-29.32%
All-time high	$54.25
All-time high date	2006-06-05
All-time low	$1.47
All-time low date	2020-03-18
Average true range (ATR)	$0.37
Average volume	5.7M
Beta (1Y)	-0.45
Beta (2Y)	-0.12
Beta (5Y)	0.53
Change from 52-week high	-41.66%
Change from 52-week low	24.31%
Change from all-time high	-81.82%
Change from all-time low	570.75%
Change from open	4.07%
Day's gap	0.52%
Dollar volume	$47.7M
High price	$9.99
Low price	$9.46
Monthly RSI	48.74
Open price	$9.58
Position in 52-week range	96.23%
Premarket change	0.31%
Premarket close	$9.53
Premarket price	$9.56
Premarket volume	1.8K
Previous close	$9.53
Price vs 150-day SMA	-23.94%
Price vs 20-day SMA	-3.8%
Price vs 200-day SMA	-26.06%
Price vs 50-day SMA	-11.39%
Relative volume	0.83
RSI	36.04
Sharpe ratio	0.4
Sharpe ratio (3Y)	0.88
Sharpe ratio (5Y)	0.33
Sortino ratio	0.74
Sortino ratio (3Y)	1.55
Sortino ratio (5Y)	0.63
Volume	4.8M
Weekly RSI	33.01
YTD price change	-8.62%
YTD total return	-8.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	235.3M
Float percentage	98.54%
Shares change (QoQ)	2.43%
Shares change (YoY)	3.21%
Shares held by insiders	1.46%
Shares held by institutions	119.7%
Shares outstanding	238.8M
Short % of float	19.19%
Short % of shares	18.91%
Short ratio	10.4 days

Deeper analysis on BKD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BKD report

Is a complete BKD research report available?

No complete published report is available for Brookdale Senior Living Inc. (BKD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Brookdale Senior Living Inc. (BKD)

Price

Financial snapshot

Fair-value bridge

Latest news · BKD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BKD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BKD

Frequently asked questions